For Immediate Release
$2.3M Sale of MOB Occupied by Community Hospital and Family Beginnings, PC.
CHICAGO, February 2, 2021 – Cushman & Wakefield announced today that the firm’s Healthcare Capital Markets team has completed the $2.3 million sale of 8435 Clearvista Place medical office building (MOB) in Indianapolis. The 13,322-square-foot MOB is occupied by Community Hospital and Family Beginnings, PC.
Cushman & Wakefield Managing Directors Gino Lollio, Scott Niedergang and Jon Owens and Associate Kyle Seychel represented Northeast Endocrinology Investments LLC in its sale to Second Moon LLC.
“The location and overall quality of the building, both in terms of its tenancy and construction, made this an attractive investment opportunity,” said Lollio. “We’ll continue to see investor interest in the MOB space accelerate in 2021 due to the sector’s growth prospects and status as an attractive destination for capital.”
Community Hospital (Moody’s: A2) is central Indiana’s leader in providing convenient access to exceptional healthcare services. Family Beginnings, PC is an ambulatory fertility facility (NPI # 1275765455) accredited by the American Association for Ambulatory Surgery Facilities (AAASF), Inc.
In 2020, the Chicago-based Healthcare Capital Markets team closed 43 transactions on 1.5 million square feet valued at more than $224 million.
About Cushman & Wakefield
Cushman & Wakefield (NYSE: CWK) is a leading global real estate services firm that delivers exceptional value for real estate occupiers and owners. Cushman & Wakefield is among the largest real estate services firms with approximately 53,000 employees in 400 offices and 60 countries. In 2019, the firm had revenue of $8.8 billion across core services of property, facilities and project management, leasing, capital markets, valuation and other services. To learn more, visit www.cushmanwakefield.com or follow @CushWake on Twitter.
The full content of this article is only available to paid subscribers. If you are an active subscriber, please log in. To subscribe, please click here: SUBSCRIBE